Flavonoids of Herba Epimedii stimulate osteogenic differentiation and suppress adipogenic differentiation of primary mesenchymal stem cells via estrogen receptor pathway

被引:28
作者
Zhang, Dawei [1 ,2 ,3 ]
Liu, Li [1 ]
Jia, Zhenbin [1 ]
Yao, Xinsheng [4 ]
Yang, Mengsu [3 ]
机构
[1] Guangdong Med Univ, Sch Pharm, Dongguan 523808, Peoples R China
[2] Guangdong Med Coll, Guangdong Key Lab Res & Dev Nat Drugs, Zhanjiang, Peoples R China
[3] City Univ Hong Kong, Dept Biomed Sci, Kowloon Tong, Hong Kong, Peoples R China
[4] Shenyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang, Peoples R China
基金
中国国家自然科学基金;
关键词
PPAR-gamma; osteogenesis; Runx-2; Adipogenesis; OSTEOBLAST DIFFERENTIATION; BONE; PROLIFERATION;
D O I
10.3109/13880209.2015.1079224
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: Accumulating evidence indicates that Herba Epimedii [Epimedii folium (Berberidaceae)] has anti-osteoporotic effect by stimulating osteoblastic bone formation and reducing osteoclastic bone resorption. However, the effect of Herba Epimedii in regulating the cross-talk between osteogenic and adipogenic differentiation of mesenchymal stem cells (MSCs) remains unclear. Objective: The present study investigates the effect of total flavonoids of Herba Epimedii (HETF) on the osteogenesis and adipogenesis of primary MSCs. Materials and methods: HETF were prepared and identified by HPLC-fingerprinting, primary mouse MSCs in the presence of 0.006-6 mu g/mL HETF for 2-10 d were subject to morphological, biochemical, and quantitative real-time PCR analysis. Results: Sixteen chemical components were identified in HETF by HPLC-fingerprinting and account for over 95% of the total area of HPLC peaks. During osteogenesis of MSCs, 0.006-6 mu g/mL HETF promoted the proliferation of MSCs from 17% to 22%, increased alkaline phosphatase activity up to 3.7-fold (0.6 mu g/mL), and extracellular calcium deposits from 1.2- to 1.4-folds by up-regulating the expression of runt-related transcription factor-2 (Runx-2) and bone morphogenetic protein-2 (BMP-2). Meanwhile, HETF suppressed the adipogenesis of MSCs by reducing the formation of adipocyte-like cells and accumulation of fat droplets by down-regulating the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma). The above biological activities of HETF were mainly through estrogen receptor-mediated pathway, which were blocked by estrogen receptor antagonist, ICI 182,780. Conclusion: HETF could regulate Runx-2-mediated osteogenesis and PPAR-gamma-mediated adipogenesis in MSCs and thus exhibit beneficial effects to bone health, which suggests a new strategy for treating patients with osteoporosis and obesity.
引用
收藏
页码:954 / 963
页数:10
相关论文
共 28 条
  • [1] Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis
    Bandyopadhyay, Amitabha
    Tsuji, Kunikazu
    Cox, Karen
    Harfe, Brian D.
    Rosen, Vicki
    Tabin, Clifford J.
    [J]. PLOS GENETICS, 2006, 2 (12) : 2116 - 2130
  • [2] Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology
    Berendsen, Agnes D.
    Olsen, Bjorn R.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (03) : 493 - 497
  • [3] TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol
    Byun, Mi Ran
    Jeong, Hana
    Bae, Su Jung
    Kim, A. Rum
    Hwang, Eun Sook
    Hong, Jeong-Ho
    [J]. BONE, 2012, 50 (01) : 364 - 372
  • [4] Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice
    Chen, Wen-Fang
    Mok, Sao-Keng
    Wang, Xin-Luan
    Lai, Ka-Hang
    Lai, Wan-Ping
    Luk, Hon-Kit
    Leung, Ping-Chung
    Yao, Xin-Sheng
    Wong, Man-Sau
    [J]. BRITISH JOURNAL OF NUTRITION, 2011, 105 (02) : 180 - 189
  • [5] [程岩 CHENG Yan], 2006, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V23, P644
  • [6] [程岩 CHENG Yan], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1135
  • [7] The bone-fat interface: basic and clinical implications of marrow adiposity
    Devlin, Maureen J.
    Rosen, Clifford J.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02) : 141 - 147
  • [8] Animal models for fracture treatment in osteoporosis
    Egermann, Marcus
    Goldhahn, J.
    Schneider, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (Suppl 2) : S129 - S138
  • [9] Control of osteoblast function and regulation of bone mass
    Harada, S
    Rodan, GA
    [J]. NATURE, 2003, 423 (6937) : 349 - 355
  • [10] The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells
    Heim, M
    Frank, O
    Kampmann, G
    Sochocky, N
    Pennimpede, T
    Fuchs, P
    Hunziker, W
    Weber, P
    Martin, I
    Bendik, I
    [J]. ENDOCRINOLOGY, 2004, 145 (02) : 848 - 859